Warrant Issuance. On the terms and subject to the conditions set forth in this Agreement, the Company shall issue to NV Investment Holdings, and NV Investment Holdings shall acquire from the Company, at the Closing, a warrant to purchase up to an aggregate of 4,000,000 fully paid and nonassessable shares of Common Stock (the “Warrant Shares”), subject to adjustment in accordance with its terms, in the form attached hereto as Annex A (the “Warrant”). The issuance of the Warrant by the Company and the acquisition of the Warrant by NV Investment Holdings are referred to herein as the “Warrant Issuance”.
Warrant Issuance. This Warrant ("WARRANT") is being issued to the holder by the Company pursuant to the Note and Warrant Purchase Agreement dated of even date herewith, between the Company and holder.
Warrant Issuance. As an inducement to Lender to enter into this Fourth Amendment and make the additional Delayed Draw Term Loans contemplated hereby, Borrower will issue to Lender a warrant (the “Warrant”) to purchase an aggregate of 1,000,000 shares of common stock of Borrower, par value $0.001 per share (the “Common Stock”), at an exercise price equal to $3.50 per share, substantially in the form of the Series G Common Stock Purchase Warrant issued by Borrower to Lender on March 25, 2020 in connection with the execution of the Agreement, on September 14, 2020 in connection with the execution of the Second Amendment to the Agreement and on December 16, 2020 in connection with the execution of the Third Amendment to the Agreement. The shares of Common Stock issuable upon exercise of the Warrant will be considered “Warrant Shares” and, therefore, “Registrable Securities” under the Registration Rights Agreement, dated March 25, 2020, between Borrower and Lender. For the avoidance of doubt, the exercise price of the Series G Common Stock Purchase Warrant issued by the Borrower to the Lender on March 25, 2020, as amended, remains at $3.70 per share, the exercise price of the Series G Common Stock Purchase Warrant issued by the Borrower to the Lender on September 14, 2020 remains at $3.25 per share, and the exercise price of the Series G Common Stock Purchase Warrant issued by the Borrower to the Lender on December 16, 2020 remains at $3.50 per share.
Warrant Issuance. On the Effective Date, the Borrower shall issue to the Holder 179,738 Warrants, each Warrant exercisable for one share of common stock of the Borrower (the “Warrant Shares”) at a price of $0.51 with a termination date being the third year anniversary of the Effective Date in the form attached hereto as Exhibit A.
Warrant Issuance. In consideration of WATERS' prior research and development activities, in the event VARIAGENICS completes an initial public offering ("IPO") on or before August 31, 2000, VARIAGENICS will issue to WATERS warrants to purchase a number of shares of VARIAGENICS Common Stock determined by the following formula: N = .15 ($7,500,000 DIVIDED BY P) Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company's application requesting confidential treatment under Rule 406 of the Securities Act. Where N is the number of shares covered by the warrants, and P is the price at which shares are offered to the public in the IPO ("IPO Price") Such warrants will be exercisable at a price equal to the IPO Price, will be immediately exercisable on issuance and will be exercisable for a period of five (5) years and will be in the form of Warrant attached hereto at Exhibit 4.7.
Warrant Issuance. As additional consideration for this Amendment No. 3, Licensee shall execute and deliver to Medtronic a warrant on the terms and in the form of the Form Warrant for that number of shares equal to (A) the aggregate amount of promissory notes issued by Licensee to Medtronic outstanding as of the date hereof multiplied by .03; divided by (B) 1.263.
Warrant Issuance. The Company will issue to each Purchaser a Warrant ---------------- to purchase one-tenth share of the Company's Common Stock at a per share exercise price of $5.75 (with such number of shares and purchase price as adjusted pursuant to the provisions of Section 3 of the Warrant for any events which occur from and after the Closing Date and on or prior to December 31, 2000) for each share of the Company's Common Stock purchased by the Purchaser at the Closing and held by such Purchaser until December 31, 2000 (the "Warrant Determination Date"). The Warrant will be issued by the Company promptly after the Warrant Determination Date; provided, however, that for purposes of calculating the amount of the Warrant, the number of shares purchased at the Closing and held until the Warrant Determination Date will be reduced by any other sales of Company securities (including short sales and sales or purchases of derivative securities) by the Purchaser from the Closing Date until the Warrant Determination Date. The Company may request an affidavit and other reasonable supporting materials as to the foregoing from any Purchaser prior to issuance of the Warrant.
Warrant Issuance. In consideration of the Lenders entry into this Agreement and the extension of credit pursuant to the New Notes, the Borrower has agreed to issue to each of the Lender a Common Stock Purchase Warrant in substantially the form attached hereto as Exhibit 2.3 to acquire up to 300,000 shares of Common Stock at an initial exercise price of $0.15 on the terms set forth therein (the “Warrant”).
Warrant Issuance. SCG shall issue (the "Warrant Issuance") warrants to purchase SCG Class B Common Shares (the "SCG Warrants") to holders of SCI Common Shares, SCI Series B Preferred Shares and Units (in each case, other than those owned by SCG) as of the Warrant Issuance Record Date on the terms and in the manner described below. The SCG Warrants shall each (i) be exercisable for one SCG Class B Common Share, (ii) have an exercise price per SCG Class B Common Share equal to the Current Market Price of an SCG Class B Common Share on the Warrant Issuance Date, (iii) shall expire 12 months from the date of issuance and (iv) shall have such other terms and conditions as set forth in the Warrant Agreement. The record date for determining the holders entitled to participate in the Warrant Issuance (the "Warrant Issuance Record Date") shall be the close of business on the date designated by SCG, which date shall be within the 28-day period following the Rights Offering Closing Date and which date shall be consistent with any restrictions in the ruling or opinion described in Section 7.1(d). SCG shall issue an aggregate number of SCG Warrants determined by dividing $101,029,642 by the Current Market Price of an SCG Class B Common Share on the Warrant Issuance Date. The number of SCG Warrants to be issued to each such holder shall be determined by multiplying (a) the aggregate number of SCG Warrants to be issued by (b) the number obtained by dividing (i) the aggregate number of SCI Common Shares held of record by the holder and issuable upon conversion of all SCI Series B Preferred Shares and upon exchange of all Units held of record by the holder, in each case as of the close of business on the Warrant Issuance Record Date, by (ii) the total number of SCI Common Shares outstanding (other than those owned by SCG) and issuable upon conversion of all SCI Series B Preferred Shares (other than those owned by SCG) and upon exchange of all Units outstanding (other than those owned by SCG), in each case as of the close of business on the Warrant Issuance Record Date. No certificates or scrip representing fractional SCG Warrants shall be issued in connection with the Warrant Issuance. The Warrant Issuance Agreement shall contain appropriate provision to aggregate and sell all fractional SCG Warrants and remit the net proceeds to the SCI shareholders who would otherwise be entitled to such fractions. The Warrant Issuance shall be made pursuant to and in accordance with the procedures set fo...
Warrant Issuance. The Warrant Agent is hereby authorized to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to clause 2.1 of the Warrant Instrument, and the Company shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.
